04:38
Ignacio Nunez Discuss Sustainability in Cell and Gene Therapy at ISCT 2024
55:56
ISCT 2024: Redefining Sustainability in CGT, Ensuring Patient Affordability and Accessibility
00:17
Multiply Labs and Wilson Wolf Collaborate to Automate G-Rex for Cell Therapy Manufacturing
03:47
Future of T Cell Manufacturing using G-Rex Closed-system Bioreactors
29:33
Evolution of Tumor-specific T Cell Production - Juan Vera | Marker Therapeutics
02:46
Will You Be Ready to Scale Your Cell Therapy Manufacturing?
01:27:51
ISCT Symposium 2021 - Defining Intelligent Scale Up and Scale Out.
04:43
G-Rex - Revolutionizing Cell Therapy Manufacturing
X
About
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry.
Tags